Shoushtari A, Olszanski AJ, Nyakas M, Hornyak TJ, et al. Pilot study of ONCOS-102 and pembrolizumab: remodeling of the tumor micro-environment and clinical outcomes in anti-PD1-resistant advanced melanoma. Clin Cancer Res 2022 Sep 16. pii: 709238. doi: 10.1158/1078-0432.CCR-22-2046.
PMID: 36112545